Clinical exome sequencing in early‐onset generalized dystonia and large‐scale resequencing follow‐up
Authors:
- 26 September 2016
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 32 (4) , 549-559
Abstract
Background: Dystonia is clinically and genetically heterogeneous. Despite being a first‐line testing tool for heterogeneous inherited disorders, whole‐exome sequencing has not yet been evaluated in dystonia diagnostics. We set up a pilot study to address the yield of whole‐exome sequencing for early‐onset generalized dystonia, a disease subtype enriched for monogenic causation.Methods: Clinical whole‐exome sequencing coupled with bioinformatics analysis and detailed phenotyping of mutation carriers was performed on 16 consecutive cases with genetically undefined early‐onset generalized dystonia. Candidate pathogenic variants were validated and tested for cosegregation. The whole‐exome approach was complemented by analyzing 2 mutated yet unestablished causative genes in another 590 dystonia cases.Results: Whole‐exome sequencing detected clinically relevant mutations of known dystonia‐related genes in 6 generalized dystonia cases (37.5%), among whom 3 had novel variants. Reflecting locus heterogeneity, identified unique variants were distributed over 5 genes (GCH1, THAP1, TOR1A, ANO3, ADCY5), of which only 1 (ANO3) was mutated recurrently. Three genes (GCH1, THAP1, TOR1A) were associated with isolated generalized dystonia, whereas 2 (ANO3, ADCY5) gave rise to combined dystonia‐myoclonus phenotypes. Follow‐up screening of ANO3 and ADCY5 revealed a set of distinct variants of interest, the pathogenicity of which was supported by bioinformatics testing and cosegregation work.Conclusions: Our study identified whole‐exome sequencing as an effective strategy for molecular diagnosis of early‐onset generalized dystonia and offers insights into the heterogeneous genetic architecture of this condition. Furthermore, it provides confirmatory evidence for a dystonia‐relevant role of ANO3 and ADCY5, both of which likely associate with a broader spectrum of dystonic expressions than previously thought. © 2016 International Parkinson and Movement Disorder Society.Keywords
Funding Information
- Else Kröner-Fresenius-Stiftung
This publication has 46 references indexed in Scilit:
- Paroxysmal exercise-induced dystonia within the phenotypic spectrum ofECHS1deficiencyMovement Disorders, 2016
- Novel Dystonia Genes: Clues on Disease Mechanisms and the Complexities of High‐Throughput SequencingMovement Disorders, 2016
- Pearls & Oy-sters: Spinocerebellar ataxia type 3 presenting with cervical dystonia without ataxiaNeurology, 2016
- Dystonia in children and adolescents: a systematic review and a new diagnostic algorithmJournal of Neurology, Neurosurgery & Psychiatry, 2014
- DystoniaCurrent Opinion in Neurology, 2014
- Genetics in dystoniaParkinsonism & Related Disorders, 2014
- A Post-Hoc Comparison of the Utility of Sanger Sequencing and Exome Sequencing for the Diagnosis of Heterogeneous DiseasesHuman Mutation, 2013
- Phenomenology and classification of dystonia: A consensus updateMovement Disorders, 2013
- Isolated generalized dystonia in biallelic missense mutations of the ATM geneMovement Disorders, 2013
- Exome sequencing identifies GCDH (glutaryl-CoA dehydrogenase) mutations as a cause of a progressive form of early-onset generalized dystoniaHuman Genetics, 2011